S. Somi

Diagnostic Performance of In‐Procedure Angiography‐Derived Quantitative Flow Reserve Compared to Pressure‐Derived Fractional Flow Reserve: The FAVOR II Europe‐Japan Study

H. Bøtker, G. Esposito, G. Campo, 2018, Journal of the American Heart Association.

Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.

J A Beliën, P. V. van Diest, J. Baak, 1999, Journal of clinical pathology.

Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.

J. Reiber, P. Serruys, A. Íñiguez, 2022, American heart journal.

Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial

A. Roguin, C. von Birgelen, G. Linssen, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A global registry of fractional flow reserve (FFR)–guided management during routine care: Study design, baseline characteristics and outcomes of invasive management

S. Achenbach, C. Berry, N. Tanaka, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years.

M. Stoel, A. Roguin, C. von Birgelen, 2020, JACC. Cardiovascular interventions.

Thin, Very Thin, or Ultrathin Strut Biodegradable- or Durable-Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.

M. Stoel, C. von Birgelen, G. Linssen, 2019, JACC. Cardiovascular interventions.

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers

M. Stoel, C. von Birgelen, G. Linssen, 2022, Journal of the American Heart Association.

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial

J. W. Louwerenburg, M. Stoel, G. Linssen, 2016, The Lancet.

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

M. Stoel, A. Roguin, C. von Birgelen, 2018, The Lancet.